Drug Watch: Agents in late-stage development for the treatment of HIV/AIDS (April 2005) (PDF)

FDA Approves First Treatment for Rare Immunodeficiency Disease

FDA Clears Narcan OTC for Opioid Overdoses

FDA Schedules Advisory Committee Meeting for OTC Contraceptive

Ohio Sues Express Scripts and Prime Therapeutics For Price Fixing

Generics Keep Out-of-Pocket Costs Low for Women with Breast Cancer

RxBenefits Provides New Solutions to Facilitate Access to Patient Assistance Programs

FDA Approves First Treatment for Rare Immunodeficiency Disease

FDA Clears Narcan OTC for Opioid Overdoses

FDA Schedules Advisory Committee Meeting for OTC Contraceptive

Ohio Sues Express Scripts and Prime Therapeutics For Price Fixing

Generics Keep Out-of-Pocket Costs Low for Women with Breast Cancer

RxBenefits Provides New Solutions to Facilitate Access to Patient Assistance Programs

FDA Approves First Treatment for Rare Immunodeficiency Disease

FDA Clears Narcan OTC for Opioid Overdoses

Related Content

FDA Schedules Advisory Committee Meeting for OTC Contraceptive

Emergent BioSolutions hasn’t provided a price for the nonprescription Narcan but said the product will be available by late summer.

Ohio Sues Express Scripts and Prime Therapeutics For Price Fixing

If approved, Perrigo’s Opill could be the first-ever nonprescription birth control pill.

Generics Keep Out-of-Pocket Costs Low for Women with Breast Cancer

The suit alleges that Express Scripts, Prime and Prime customer Humana Pharmacy Solutions are able to share drug pricing and rebate information to increase prices for insulins, biologics and cancer drugs.

RxBenefits Provides New Solutions to Facilitate Access to Patient Assistance Programs

Out-of-pockets costs were higher among those using branded or more recently launched drugs.

FDA Approves First Treatment for Rare Immunodeficiency Disease

RxBenefits helps patients in self-funded plans find and apply for alternative sources of funding for specialty medicines and facilitates enrollment.